Health Products

Mitoxantrone injection USP (2014-11-21)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
A024636AC
Recalling Firm
Hospira Healthcare Corporation
Suite 600 - 1111 Dr. Frederik Philips Blvd
Saint-Laurent
H4M 1X6
Quebec
CANADA
Marketing Authorization Holder
Hospira Healthcare Corporation
Suite 600 - 1111 Dr. Frederik Philips Blvd
Saint-Laurent
H4M 1X6
Quebec
CANADA
Mitoxantrone injection USPSolutionDIN 022446142 mg/mL

Introduction

Recalled products

Mitoxantrone injection USP

Reason

Lot A024636AC did not meet the specification for the individual unknown impurity during the stability testing.

Depth of distribution

Retailers
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime